Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Apr 16, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

Optimization of cell line development in the GS-CHO expression system using a high-throughput, single cell-based

Tsuyoshi Nakamura¹, Takeshi Omasa²

¹Institute of Technology and Science, Tokushima University, 2-1 Minamijosanjima-cho, Tokushima 770-8506, Japan; Astellas Pharma Inc., 2-5-1 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan.

Journal of Bioscience and Bioengineering

|March 21, 2015

Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Artificial induction of bottlenecks in the endoplasmic reticulum for rational improvement of antibody secretion in Chinese hamster ovary cells.

New biotechnology·2026

Same author

Manufacture of adeno-associated virus vectors by a novel human-derived cell line HAT and comprehensive evaluation of the vectors.

Molecular therapy. Advances·2026

Same author

Linear ubiquitination triggers Amph-mediated T-tubule biogenesis.

Science advances·2026

Same author

Redefining media blending mathematically: a systematic approach for screening of medium components.

Applied microbiology and biotechnology·2025

Same author

Comparative omics profiling reveals differences in biomass, energy production, and vesicle transport between CHO and fast-growing CHL-YN cells.

Scientific reports·2025

Same author

Variation of VP2 stoichiometry and deamidation of VP1 during production and their impacts on the transduction efficiency of AAV vectors.

Molecular therapy. Methods & clinical development·2025

Optimizing cell culture conditions and plating times with the ClonePix FL system enhances high-producing clone selection for therapeutic antibody production using Chinese hamster ovary (CHO) cells.

Area of Science:

Biotechnology
Cell Line Development
Mammalian Cell Culture

Background:

Chinese hamster ovary (CHO) cells are the primary host for therapeutic antibody production due to their safety and regulatory approval.
The glutamine synthetase (GS) gene expression system is utilized in CHO-K1SV cells for efficient protein production.
Traditional limiting dilution cloning is inefficient for isolating high-producing, monoclonal CHO cell lines.

Purpose of the Study:

To optimize the ClonePix FL system for high-throughput single-cell cloning of CHO-K1SV cells.
To improve the efficiency and monoclonality of high-producing clone selection.
To identify key factors influencing successful single-cell clone selection.

Main Methods:

Application of the automated ClonePix FL system for single-cell selection.

Keywords:

Cell line development Chinese hamster ovary cell Glutamine synthetase High-throughput selection Semi-solid media

More Related Videos

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

Rapid Optimization of a Light-Inducible System to Control Mammalian Gene Expression

Rapid Optimization of a Light-Inducible System to Control Mammalian Gene Expression

Published on: November 4, 2025

Related Experiment Videos

Last Updated: Apr 16, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

Rapid Optimization of a Light-Inducible System to Control Mammalian Gene Expression

Rapid Optimization of a Light-Inducible System to Control Mammalian Gene Expression

Published on: November 4, 2025

Optimization of semi-solid medium formulation for pre-picking cell growth.

Adjustment of plating time for improved post-picking cell growth and efficiency.

Main Results:

Optimized semi-solid medium formulation enhanced CHO-K1SV cell growth before picking.
Adjusted plating times improved post-picking cell growth and selection efficiency without reducing clone diversity.
Medium formulation and selection conditions were identified as critical for establishing high-producing CHO cell lines.

Conclusions:

The ClonePix FL system, combined with optimized medium and plating conditions, significantly improves the selection of high-producing CHO cell clones.
This approach enhances efficiency and monoclonality in cell line development for biopharmaceutical manufacturing.
Optimized single-cell selection is crucial for constructing robust and productive CHO cell lines for therapeutic antibody production.